Part A Placebo

BIOLOGICAL2 trials

Sponsors

Stealth BioTherapeutics Inc., DBV Technologies

Conditions

Fuchs' Corneal Endothelial Dystrophy (FCED)Peanut Allergy

Phase 1

A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide Topical Ophthalmic Solution for the Treatment of Fuchs' Corneal Endothelial Dystrophy (FCED)

CompletedNCT02653391

Stealth BioTherapeutics Inc.Fuchs' Corneal Endothelial Dystrophy (FCED)

Start: 2016-02-29End: 2018-12-31Updated: 2021-09-17

Phase 3

Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age

CompletedNCT03211247

DBV TechnologiesPeanut Allergy

Start: 2017-07-31End: 2022-04-27Updated: 2024-12-16

Related Papers

Efficacy and safety of epicutaneous immunotherapy in children with peanut allergy with atopic comorbidities

Annals of Allergy Asthma & Immunology2025-04-081 citations

Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy

New England Journal of Medicine2023-05-10115 citations